GLP-1 & metabolic
Compounded semaglutide
Also known as: compounded GLP-1, custom-made semaglutide
Plain-language summary
Semaglutide prepared by compounding pharmacies rather than the FDA-approved manufacturer. The molecule may be the same, but these specific products are not FDA-reviewed or approved.
Regulatory status
Compounded and unapproved products are not FDA-reviewed for safety, effectiveness, or quality.
Evidence snapshot
Insufficient. There is not enough credible human evidence to draw a conclusion for the use described.
How it works
If it contains genuine semaglutide, the mechanism is the same GLP-1 receptor agonism as approved products; however, purity, actual content, and salt form are not guaranteed.
Approved uses and researched uses
FDA-approved uses
None. This product has no FDA-approved use for the context described.
Researched (not approved) uses
- Weight loss and diabetes management (as unregulated substitutes for approved products)
Researched uses are studied but not FDA-approved and may be off-label. This is not a recommendation to use them.
Known risks and uncertainties
In addition to the known GI and pancreatic risks of semaglutide, the FDA has received adverse-event reports tied to compounded GLP-1s, including dosing errors from patient self-measurement, use of unapproved salt forms, contamination, and hospitalizations. Some marketed products are counterfeit.
Cautions and contraindications
Same clinical contraindications as semaglutide (thyroid C-cell tumor history, MEN 2), plus the added uncertainty that the actual contents and dose may not match the label.
Consumer considerations
- These products are not FDA-approved and are not reviewed for safety, quality, or potency.
- Vials requiring self-measurement create a real risk of overdosing.
- Some online sellers use false labels or nonexistent pharmacy names.
- Availability often increased during brand shortages, but that does not make them FDA-verified.
- An FDA-approved brand product is the way to get a reviewed formulation.
Questions to ask a licensed clinician
- Why is a compounded version being recommended instead of an FDA-approved product?
- What pharmacy is compounding it and is it state-licensed and reputable?
- How do I measure and inject the correct dose safely?
- What are the warning signs of an overdose or contamination reaction?
- Would an approved brand product be accessible or affordable for me instead?
Sources
Primary and authoritative sources
- 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
- 2.FDA Warns Telehealth Companies Against Illegal Marketing of Compounded GLP-1s — U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
Reviewed by Peptides Clarified Editorial — Editorial sourcing review — licensed clinical review pending.